{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:32:48Z","timestamp":1775313168286,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":6079,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1992,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Different factors are involved in the development of thrombocytopenia in patients with lymphoproliferative disorders. Significant correlation was detected between the number of megakaryocytes in bone marrow and platelet count (r = 0.485, p = 0.002, n = 37) and significant difference between the number of megakaryocyte in patients with normal platelet count (&gt;200000\/\u03bcl) and patients with marked thrombocytopenia (platelet count &lt; 100000\/\u03bcl). All patients in the latter group (n = 15) had a relatively low number of megakaryocytes. Low but significant reverse correlation was found between the level of platelet\u2010associated IgG (PA\u2010IgG) and platelet count (r = \u2013 0.249, p = 0.024, n = 82) and significant difference between the mean levels of PA\u2010IgG in the groups of patients with platelet count &gt; 200000\/\u03bcl and &lt; 100000\/\u03bcl. PA\u2010IgG were increased in 46% of patients in the total group and in 65% of patients with platelet count &lt; 100000\/\u03bcl. The correlation between platelet count and PA\u2010IgG was about 2 times higher in splenectomized (r= \u2013 0.549, p = 0.005, n = 24) than nonsplenectomized patients. All splenectomized patients with platelet count &lt; 100000\/\u03bcl (n = 8) had a significant increase in PA\u2010IgG. Serum antibodies were detected in only 7% of tested patients. This group was characterized by severe thrombocytopenia (in 6 of 10 patients \u2013 platelet count &lt;50000\/\u03bcl) and a high incidence of haemorrhages (in 5 of 10 patients). Thus the depression of platelet production was suggested to be the basic cause of thrombocytopenia in lymphoproliferative disorders. Involvement of immune mechanisms was revealed in a large number of patients and correlated with a deeper and more complicated thrombocytopenia.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1992.tb00913.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T12:00:24Z","timestamp":1279454424000},"page":"113-118","source":"Crossref","is-referenced-by-count":17,"title":["Mechanisms of thrombocytopenia in patients with lymphoproliferative diseases"],"prefix":"10.1111","volume":"49","author":[{"given":"A. I.","family":"Kuznetsov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. I.","family":"Idelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Mazurov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical studying of chronic lymphocytic leukaemia","volume":"46","author":"Rai KP","year":"1975","journal-title":"Blood"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02727.x"},{"key":"e_1_2_1_4_2","first-page":"264","article-title":"Study and therapy of chronic lymphocytic leukaemia","volume":"24","author":"Foon KA","year":"1987","journal-title":"Semin Haematol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V19.1.23.23","article-title":"Autoimmune thrombocytopenic purpura (\u201cITP\u201d type) with chronic lymphocytic leukaemia","volume":"19","author":"Ebbe S.","year":"1962","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860715)58:2<234::AID-CNCR2820580206>3.0.CO;2-E"},{"key":"e_1_2_1_7_2","first-page":"403","article-title":"Incidence and prognostic significance of autoantibodies against erytrocytes and platelets in chronic lymphocytic leukaemia (CLL)","volume":"30","author":"Rossi G.","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_8_2","first-page":"123","article-title":"Indirect platelet radioactive antiglobulin test in patients with lymphoproliferative disease","volume":"107","author":"Garvey MB","year":"1986","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V63.4.944.944","article-title":"Platelet associated IgG in patients with lymphoma","volume":"63","author":"Berkman AW","year":"1984","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/blood.V53.4.545.545","article-title":"Immune thrombocytopenia in lymphoproliferative disease","volume":"53","author":"Kaden BR","year":"1979","journal-title":"Blood"},{"key":"e_1_2_1_11_2","first-page":"253","article-title":"Splenectomy for thrombocytopenia in chronic lymphocytic leukaemia","volume":"15","author":"Merl SA","year":"1983","journal-title":"Int J Haematol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90243-6"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19870115)59:2<340::AID-CNCR2820590229>3.0.CO;2-A"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(78)91322-0"},{"key":"e_1_2_1_15_2","first-page":"464","article-title":"A monoclonal antibody, VM64, reacts with 130 kDa glycoprotein common to platelets and endothelial cells: heterogeneity in antibody binding to human aortic endothelial cells","volume":"66","author":"Mazurov AV","year":"1991","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_16_2","first-page":"14","article-title":"Shape and functional properties of human platelets washed with citrate","volume":"10","author":"Patcheke H.","year":"1981","journal-title":"Haemostasis"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198105073041904"},{"key":"e_1_2_1_18_2","first-page":"194","article-title":"Complement\u2010mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease","volume":"316","author":"Lechman HA","year":"1987","journal-title":"New Engl J Med"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830240404"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1992.tb00913.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1992.tb00913.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T16:56:50Z","timestamp":1698080210000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1992.tb00913.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,9]]}},"alternative-id":["10.1111\/j.1600-0609.1992.tb00913.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1992.tb00913.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,9]]}}}